Forum Finance Group’s Moderna MRNA Stock Holding History

Forum Finance Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$566K	Sell	10,000 -400	-4%	-$20.7K	0.2%	96
2026 Q1	$416K	Buy	+10,400	New	+$485K	0.23%	85

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Forum Finance Group's MRNA Position: Q2 2026 in Review

Forum Finance Group reduced its Moderna (MRNA) stake by 3.8% in Q2 2026, selling an estimated $20.7K and leaving 10,000 shares worth $566K. The position accounts for 0.2% of the portfolio, ranked #96.

Forum Finance Group first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Forum Finance Group held 10,000 shares of Moderna worth $566K as of Q2 2026.
Forum Finance Group sold 400 Moderna shares in Q2 2026, an estimated $20.7K.
Moderna made up 0.2% of Forum Finance Group's portfolio in Q2 2026, its #96 holding.
Forum Finance Group first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Forum Finance Group's 13F filing for Q2 2026, filed 14 Aug 2026.